Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanguine Biosciences is a technology-enabled health services company that accelerates precision medicine by connecting medical researchers directly with patients. The company specializes in direct-to-patient recruitment and mobile health (mHealth) services, facilitating the collection of high-quality biospecimens and longitudinal data within the comfort of a patient's home. By leveraging a proprietary digital platform and a national network of mobile phlebotomists, Sanguine supports clinical trials and discovery research across diverse therapeutic areas, including oncology, immunology, and rare diseases. Their patient-centric model reduces the logistical burden on participants while providing researchers with well-characterized, gold-standard samples. Sanguine's services are utilized by many of the world's leading pharmaceutical and biotechnology companies to streamline drug development and biomarker discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanguine Life Sciences.